RNU7-200P

Across TCGA pan-cancer cohorts, RNU7-200P RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of RNU7-200P’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where RNU7-200P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNU7-200P is over-expressed in tumor.

BRCA, STAD, and LUAD are the cancer types where RNU7-200P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNU7-200P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	Female	II,III,IV	+0.136	.027	4	view →
STAD	Male	II,III,IV	+0.325	.026	2	view →
LUAD	All	All	+0.293	.024	1	view →
LUSC	All	II,III,IV	+0.163	.039	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

RNU7-200P–BRCA

Open the BRCA breakdown →